NCT05019404

Brief Summary

Temporal lobe epilepsy (TLE) is a chronically neurological disease characterized by progressive seizures. TLE is the most frequent subtype of refractory focal epilepsy in adults. Epilepsy surgery has proven to be very efficient in TLE and superior to medical therapy in two randomized controlled trials. According to the previous experience, the investigators use functional anterior temporal lobectomy (FATL) via minicraniotomy for TLE. To date, this minimally invasive open surgery has been not reported. The investigators here present a protocol of a prospective trail which for the first time evaluates the outcomes of this new surgical therapy for TLE.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 24, 2021

Completed
1.7 years until next milestone

Study Start

First participant enrolled

April 25, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

December 30, 2022

Status Verified

November 1, 2022

Enrollment Period

1.4 years

First QC Date

July 9, 2021

Last Update Submit

December 28, 2022

Conditions

Keywords

Temporal lobe epilepsyAnterior temporal lobectomyFunctional anterior temporal lobectomyRandomized controlled trialMinicraniotomy

Outcome Measures

Primary Outcomes (6)

  • Surgery duration

    Surgery duration in hours, the time from the beginning of incising the skin to the finish of suturing the skin.

    At the end of the surgery.

  • Blood loss

    Blood loss in millilitres during the operation.

    At the end of the surgery.

  • Skin incision

    Length of skin incision in centimetres

    At the end of the surgery.

  • Bone flap

    Size of bone flap in square centimeter

    At the end of the surgery.

  • Postoperative hospital stay

    Postoperative hospital stay in days, the time from the first postoperative day to discharge date.

    Up to 1 month after surgery.

  • Complications

    The incidence of postoperative complications

    Up to 1 year after epilepsy surgery

Secondary Outcomes (3)

  • Seizure outcomes classified by the International League Against Epilepsy (ILAE)

    Up to 1 year after epilepsy surgery

  • Seizure outcomes classified by the Engel

    Up to 1 year after epilepsy surgery

  • Quality of life assessed by the Quality of Life in Epilepsy Inventory- 89

    Up to 1 year after epilepsy surgery

Other Outcomes (3)

  • Intelligence assessed by the Wechsler Adult Intelligence Scale

    Up to 1 year after epilepsy surgery

  • Depression assessed by Beck's Depression Inventory

    Up to 1 year after epilepsy surgery

  • Anxiety assessed by the State-Trait Anxiety Inventory

    Up to 1 year after epilepsy surgery

Study Arms (2)

Functional anterior temporal lobectomy (FATL)

EXPERIMENTAL

FATL via minicraniotomy is a new surgical approach, consisting of amygdalohippocampectomy and the lateral temporal lobotomy.

Procedure: Functional anterior temporal lobectomy (FATL)

Anterior temporal lobectomy (ATL)

ACTIVE COMPARATOR

ATL via large frontotemporal craniotomy is a conventional surgical approach, consisting of amygdalohippocampectomy and en bloc resection of the lateral temporal lobe.

Procedure: Anterior temporal lobectomy (ATL)

Interventions

Patients are placed in the supine position with the head contralaterally rotated 30°. The 3D model of incision and bone flap is printed prior to surgery by the slicer software based on the MRI data. Slightly curve incision with the length of about 6 cm in the temporal region is marked according to the 3D model. Temporal craniotomy via small bone window with the diameter of about 3 cm is performed. From the temporal pole along T1 about 5 cm posteriorly, temporal horn is opened by dissecting the middle temporal gyrus. The head of temporal horn is exposed. The amygdala is resected. Then, the parahippocampal gyrus and hippocampus are en bloc resected. The lateral temporal lobotomy is easy due to large view following the removal of mesial structures. The lateral posterior temporal lobotomy is no more than 5 cm from the temporal pole.

Functional anterior temporal lobectomy (FATL)

Patients are placed in the supine position with the head contralaterally rotated 30°. Large frontotemporal craniotomy is performed. Question mark-shaped incision with the length of 20- 25 cm in the frontotemporal region is marked. The size of the bone flap is approximately 5×7 cm for the exposure of lateral temporal lobe. ATL consists of en bloc resection of the anterior 5 cm of lateral temporal lobe, followed by the removal of mesial structures including the amygdala, parahippocampal gyrus, and hippocampus.

Anterior temporal lobectomy (ATL)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • male or female aged between 18 and 60 years;
  • drug- resistant temporal lobe epilepsy, remaining seizures after two or more tolerated and appropriately chosen antiepileptic drugs;
  • monthly or more seizures during the preceding year prior to trial;
  • the full- scale intelligence quotient (IQ) more than 70, understanding and completing the trial;
  • signing the informed consent;
  • good compliance, at least 12- month follow- up after surgery.

You may not qualify if:

  • tumor in temporal lobe;
  • extratemporal epilepsy and temporal plus epilepsy;
  • drug- responsive epilepsy, seizure freedom with current drugs in recent one year;
  • pseudoseizures;
  • seizures arising from bilateral temporal lobes;
  • significant comorbidities including progressive neurological disorders, active psychosis, and drug abuse;
  • a full- scale IQ lower than 70, unable to complete tests;
  • previous epilepsy surgery;
  • poor compliance and inadequate follow- up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, 710061, China

RECRUITING

Related Publications (16)

  • O'Dell CM, Das A, Wallace G 4th, Ray SK, Banik NL. Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review. J Neurosci Res. 2012 May;90(5):913-24. doi: 10.1002/jnr.22829. Epub 2012 Feb 8.

    PMID: 22315182BACKGROUND
  • Falowski SM, Wallace D, Kanner A, Smith M, Rossi M, Balabanov A, Ouyang B, Byrne RW. Tailored temporal lobectomy for medically intractable epilepsy: evaluation of pathology and predictors of outcome. Neurosurgery. 2012 Sep;71(3):703-9; discussion 709. doi: 10.1227/NEU.0b013e318262161d.

    PMID: 22668889BACKGROUND
  • Jones AL, Cascino GD. Evidence on Use of Neuroimaging for Surgical Treatment of Temporal Lobe Epilepsy: A Systematic Review. JAMA Neurol. 2016 Apr;73(4):464-70. doi: 10.1001/jamaneurol.2015.4996.

    PMID: 26926529BACKGROUND
  • Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001 Aug 2;345(5):311-8. doi: 10.1056/NEJM200108023450501.

    PMID: 11484687BACKGROUND
  • Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, Sperling MR, Gardiner I, Erba G, Fried I, Jacobs M, Vinters HV, Mintzer S, Kieburtz K; Early Randomized Surgical Epilepsy Trial (ERSET) Study Group. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012 Mar 7;307(9):922-30. doi: 10.1001/jama.2012.220.

    PMID: 22396514BACKGROUND
  • Chang EF, Englot DJ, Vadera S. Minimally invasive surgical approaches for temporal lobe epilepsy. Epilepsy Behav. 2015 Jun;47:24-33. doi: 10.1016/j.yebeh.2015.04.033. Epub 2015 May 24.

    PMID: 26017774BACKGROUND
  • Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Epilepsia. 2003 Jun;44(6):741-51. doi: 10.1046/j.1528-1157.2003.48202.x.

    PMID: 12790886BACKGROUND
  • Choi H, Sell RL, Lenert L, Muennig P, Goodman RR, Gilliam FG, Wong JB. Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA. 2008 Dec 3;300(21):2497-505. doi: 10.1001/jama.2008.771.

    PMID: 19050193BACKGROUND
  • Tebo CC, Evins AI, Christos PJ, Kwon J, Schwartz TH. Evolution of cranial epilepsy surgery complication rates: a 32-year systematic review and meta-analysis. J Neurosurg. 2014 Jun;120(6):1415-27. doi: 10.3171/2014.1.JNS131694. Epub 2014 Feb 21.

    PMID: 24559222BACKGROUND
  • Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, Sperling MR, Luders H, Pedley TA; Commission on Neurosurgery of the International League Against Epilepsy (ILAE). ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001 Feb;42(2):282-6. No abstract available.

    PMID: 11240604BACKGROUND
  • Zhao Y, Ding C, Wang Y, Li Z, Zhou Y, Huang Y. Reliability and validity of a Chinese version of the Quality of Life in Epilepsy Inventory (QOLIE-89). Epilepsy Behav. 2007 Aug;11(1):53-9. doi: 10.1016/j.yebeh.2007.03.013. Epub 2007 May 10.

    PMID: 17499025BACKGROUND
  • Brissart H, Planton M, Bilger M, Bulteau C, Forthoffer N, Guinet V, Hennion S, Kleitz C, Laguitton V, Mirabel H, Mosca C, Pecheux N, Pradier S, Samson S, Tramoni E, Voltzenlogel V, Denos M, Boutin M. French neuropsychological procedure consensus in epilepsy surgery. Epilepsy Behav. 2019 Nov;100(Pt A):106522. doi: 10.1016/j.yebeh.2019.106522. Epub 2019 Oct 15.

    PMID: 31627076BACKGROUND
  • Schmeiser B, Wagner K, Schulze-Bonhage A, Mader I, Wendling AS, Steinhoff BJ, Prinz M, Scheiwe C, Weyerbrock A, Zentner J. Surgical Treatment of Mesiotemporal Lobe Epilepsy: Which Approach is Favorable? Neurosurgery. 2017 Dec 1;81(6):992-1004. doi: 10.1093/neuros/nyx138.

    PMID: 28582572BACKGROUND
  • Tellez-Zenteno JF, Dhar R, Wiebe S. Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain. 2005 May;128(Pt 5):1188-98. doi: 10.1093/brain/awh449. Epub 2005 Mar 9.

    PMID: 15758038BACKGROUND
  • Brotis AG, Giannis T, Kapsalaki E, Dardiotis E, Fountas KN. Complications after Anterior Temporal Lobectomy for Medically Intractable Epilepsy: A Systematic Review and Meta-Analysis. Stereotact Funct Neurosurg. 2019;97(2):69-82. doi: 10.1159/000500136. Epub 2019 Jul 9.

    PMID: 31288240BACKGROUND
  • Bjellvi J, Flink R, Rydenhag B, Malmgren K. Complications of epilepsy surgery in Sweden 1996-2010: a prospective, population-based study. J Neurosurg. 2015 Mar;122(3):519-25. doi: 10.3171/2014.9.JNS132679. Epub 2014 Oct 31.

    PMID: 25361484BACKGROUND

MeSH Terms

Conditions

Epilepsy, Temporal Lobe

Interventions

Anterior Temporal Lobectomy

Condition Hierarchy (Ancestors)

Epilepsies, PartialEpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEpileptic Syndromes

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeNeurosurgical Procedures

Study Officials

  • Hua Zhang, PhD

    First Affiliated Hospital Xi'an Jiaotong University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessors are blinded to the treatment throughout the entire study. Blinding is maintained by having patients wear large hats during the interview to obscure skin incision and providing patients strict instruction not to reveal treatment arm.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: a single-center, prospective, single-blinded, double-arm, randomized, controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2021

First Posted

August 24, 2021

Study Start

April 25, 2023

Primary Completion

September 1, 2024

Study Completion

September 1, 2025

Last Updated

December 30, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

There is not a plan to make individual participant data (IPD) available to other researchers.

Locations